List of National Jewish Health patents

Patents where

Current Assignee

Name

National Jewish Health

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7468048 Joint aspirate facilitating device	Patent 7468048 was granted and assigned to National Jewish Health on December, 2008 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	7468048	December 23, 2008
‌ US Patent 11468564 Systems and methods for automatic detection and quantification of pathology using dynamic feature classification	Patent 11468564 was granted and assigned to National Jewish Health on October, 2022 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11468564	October 11, 2022
‌ US Patent 11494902 Systems and methods for automatic detection and quantification of pathology using dynamic feature classification	Patent 11494902 was granted and assigned to National Jewish Health on November, 2022 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11494902	November 8, 2022
‌ US Patent 7790762 Compounds and methods for thiol-containing compound efflux and cancer treatment	Patent 7790762 was granted and assigned to National Jewish Health on September, 2010 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	7790762	September 7, 2010
‌ US Patent 8961490 Disposable vial holder and method to prevent needle stick injuries	Patent 8961490 was granted and assigned to National Jewish Health on February, 2015 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	8961490	February 24, 2015
‌ US Patent 11278556 Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs		National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11278556	March 22, 2022
‌ US Patent 8178098 Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies	Patent 8178098 was granted and assigned to National Jewish Health on May, 2012 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	8178098	May 15, 2012
‌ US Patent 11649503 Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders	Patent 11649503 was granted and assigned to National Jewish Health on May, 2023 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11649503	May 16, 2023
‌ US Patent 7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness	Patent 7582300 was granted and assigned to National Jewish Health on September, 2009 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	7582300	September 1, 2009
‌ US Patent 11382895 Methods for treating injury associated with exposure to an alkylating species			National Jewish Health	United States Patent and Trademark Office	11382895	July 12, 2022
‌ US Patent 11209434 Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases	Patent 11209434 was granted and assigned to National Jewish Health on December, 2021 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11209434	December 28, 2021
‌ US Patent 11351141 Methods and compositions for treating infection and inflammation with selenocyanate	Patent 11351141 was granted and assigned to National Jewish Health on June, 2022 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11351141	June 7, 2022
‌ US Patent 10415027 Treatment for airway cast obstruction	Patent 10415027 was granted and assigned to National Jewish Health on September, 2019 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	10415027	September 17, 2019
‌ US Patent 10054589 Methods to identify and treat subjects having corticosteroid-resistant asthma	Patent 10054589 was granted and assigned to National Jewish Health on August, 2018 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	10054589	August 21, 2018
‌ US Patent 11225651 Treatment for airway cast obstruction	Patent 11225651 was granted and assigned to National Jewish Health on January, 2022 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11225651	January 18, 2022
‌ US Patent 7825089 Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto	Patent 7825089 was granted and assigned to National Jewish Health on November, 2010 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	7825089	November 2, 2010
‌ US Patent 9624543 Markers for diagnosis of pulmonary inflammation and methods related thereto	Patent 9624543 was granted and assigned to National Jewish Health on April, 2017 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	9624543	April 18, 2017
‌ US Patent 9314479 Methods and compositions for the disruption of biofilms	Patent 9314479 was granted and assigned to National Jewish Health on April, 2016 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	9314479	April 19, 2016
‌ US Patent 11002740 Methods of detecting and reducing cancer cell central nervous system colonization	Patent 11002740 was granted and assigned to National Jewish Health on May, 2021 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	11002740	May 11, 2021
‌ US Patent 10706533 Systems and methods for automatic detection and quantification of pathology using dynamic feature classification	Patent 10706533 was granted and assigned to National Jewish Health on July, 2020 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	10706533	July 7, 2020
‌ US Patent 9505819 Genes and proteins associated with angiogenesis and uses thereof	Patent 9505819 was granted and assigned to National Jewish Health on November, 2016 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	9505819	November 29, 2016
‌ US Patent 9383374 Methods to determine susceptibility to treatment with leukotriene modifiers	Patent 9383374 was granted and assigned to National Jewish Health on July, 2016 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	9383374	July 5, 2016
‌ US Patent 10369194 Methods to treat allergic conditions with PIM1 kinase inhibitor	Patent 10369194 was granted and assigned to National Jewish Health on August, 2019 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	10369194	August 6, 2019
‌ US Patent 7825224 Product and method for treatment of conditions associated with receptor-desensitization	Patent 7825224 was granted and assigned to National Jewish Health on November, 2010 by the United States Patent and Trademark Office.		National Jewish Health	United States Patent and Trademark Office	7825224	November 2, 2010
‌ US Patent 10100309 Targeting the steroidogenic pathway for treating and/or preventing allergic diseases	Patent 10100309 was granted and assigned to National Jewish Health on October, 2018 by the United States Patent and Trademark Office.	National Jewish Health	National Jewish Health	United States Patent and Trademark Office	10100309	October 16, 2018

Results per page:

68 results

0 selected

68 results

0 selected